chrisvoncsefalvay/vaers-outcomes huggingface dataset:
4 year old male dx with L arm cellulitis secondary to immunizations. Pt received his 4 year old vaccines on 06/06/08 and L arm cellulitis developed on 06/08/08. Keflex and bactrim Rx given at PO on 06/09/08.
PATIENT WAS ADMINISTERED BOOSTRIX ON 05/24/18. SHE DID NOT HAVE ANY REACTIONS/SYMPTOMS UNTIL MONDAY (05/28/18), WHEN SHE NOTICED ITCHY RASH ON HER STOMACH, THIGHS AND FOREARMS WHICH HAD GOTTEN WORSE OVER THE NEXT FEW DAYS. SHE USED BENADRYL CREAM TO GET SOME RELIEF. BY THURSDAY 05/31/18, HER RASH HAD SPREAD AND HER KNEES WERE ALSO SWOLLEN AND FELT WARM. PATIENT CALLED THE DOCTOR AND IS SCHEDULED TO BE SEEN ON 06/01/2018.
Sudden onset of vertigo, hot/cold flashes, fainting and disorientation. Taken from home by ambulance to ER.
NONE. PATIENT RECEIVED EXPIRED MODERNA WITHOUT ADVERSE REACTIONS. MODERNA EXPIRED ON 10/13/2021 AND GIVEN ON 10/28/2021
About a couple minutes a receiving the vaccine I started having a metal taste in my mouth. My right side of my face started to tingle and then felt almost as if it was numb or paralyzed. It lasted for about 15 or 20 minutes.
After Moderna vaccine I had chills started night of vaccine on 1/6/2021 and noon on 1/7/2021 extreme fatigue, nausea, chills and heart rate of 35 and oxygen in 90. On 1/8/2021 I am much better.
Shortness of breath wakes him up from his sleep; Crackling in my throat; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA PAROXYSMAL NOCTURNAL (Shortness of breath wakes him up from his sleep) in a 53-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 047B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 20-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Apr-2021, the patient experienced DYSPNOEA PAROXYSMAL NOCTURNAL (Shortness of breath wakes him up from his sleep) (seriousness criterion medically significant) and CREPITATIONS (Crackling in my throat). On 23-Apr-2021, DYSPNOEA PAROXYSMAL NOCTURNAL (Shortness of breath wakes him up from his sleep) had resolved. At the time of the report, CREPITATIONS (Crackling in my throat) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided.  Treatment information was unknown.
Side effects; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 21-May-2021 and was forwarded to Moderna on 01-Jun-2021.    This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (Side effects) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (Side effects). At the time of the report, VACCINATION COMPLICATION (Side effects) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Relevant concomitant product usage were not reported by the reporter. No treatment details were added.
Pancreatitis; kidney failure; Diabetes Ketoacidosis; legal blindness; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 23-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 22Dec2021 at 12:00 as dose 2, single (Batch/Lot number: unknown) at the age of 23 years, in right arm for covid-19 immunisation. The patient's relevant medical history included: "Birth control" (unspecified if ongoing). The patient took concomitant medications. Vaccination history included: Bnt162b2 (Dose Number: 1, Product: COVID 19, Brand: Pfizer,, Lot unknown reason: Unable to locate or read the details, Administration date: Oct2021, Vaccine location: Left arm), administration date: Oct2021, for COVID-19 immunization. The following information was reported: DIABETIC KETOACIDOSIS (caused and prolonged hospitalization, disability, medically significant, life threatening) with onset 27Dec2021, outcome "recovered with sequelae", described as "Diabetes Ketoacidosis"; PANCREATITIS (hospitalization, disability, medically significant, life threatening) with onset 27Dec2021, outcome "recovered with sequelae"; RENAL FAILURE (caused and prolonged hospitalization, disability, medically significant, life threatening) with onset 27Dec2021, outcome "recovered with sequelae", described as "kidney failure"; BLINDNESS (caused and prolonged hospitalization, disability, medically significant, life threatening) with onset 27Dec2021, outcome "recovered with sequelae", described as "legal blindness". The patient was hospitalized for pancreatitis (hospitalization duration: 16 day(s)); for renal failure, diabetic ketoacidosis, blindness (hospitalization duration: 16 day(s)). The events "pancreatitis", "kidney failure", "diabetes ketoacidosis" and "legal blindness" required emergency room visit. Therapeutic measures were taken as a result of pancreatitis, renal failure, diabetic ketoacidosis, blindness.  Clinical course: There was no other vaccine in four weeks. Other medications in two weeks for birth control. Patient was hospitalized with resulting dialysis, vision changes resulting in legal blindness. Patient was hospitalized for 16 days. The patient was recovered with lasting effects. There was treatment for AE included hospitalization, dialysis, insulin therapy. There was no COVID prior vaccination. There was no COVID tested post vaccination. There was no known allergies. There was no other medical history prior to adverse reaction.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
patient had waited 13 months between both doses; This non-serious case was reported by a physician via call center representative and described the occurrence of drug dose administration interval too long in a 58-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (received 1st dose on 30th September 2022 with batch number LG2XJ).   In OCT-2023, the patient received the 2nd dose of Shingrix. In OCT-2023, an unknown time after receiving Shingrix, the patient experienced drug dose administration interval too long (Verbatim: patient had waited 13 months between both doses). The outcome of the drug dose administration interval too long was unknown.   Additional Information: GSK receipt date: 04-OCT-2023 A physician called in to request information about the administration of the second dose of Shingrix after a patient had waited 13 months between both doses.  Partial information was given, as well as consent to follow-up. The patient received 2nd dose of Shingrix, later than the recommended interval, which led to lengthening of vaccination schedule.
Severe pain in left arm, from the shoulder to the elbow of left arm felt heavy and very painful for two days.  I started my menstrual cycle the day after the vaccination - two weeks early. I am on birth control and my dates have not varied in twenty years until this time. It has been an abnormally heavy cycle with very painful cramps this time too - things which I have not had since I was in my early twenties (and never since I have been on birth control).
Urticaria, started <24 hours after vaccine administration.  treated with benadryl.
Myalgia, Fever,  fatigue, chills  Narrative:  6-8 hours after the vaccine had chills and body aches. This  lasted until the next day - 24-30 hours. She also developed a low grade fever  to 100 degrees. Symptoms resolved by Thursday 1/7.
Voice mail left directly from the parent of patient.  "Hi I'm calling for patient and my question is on Monday he got three vaccines on his left arm and I understand it's supposed to be swollen but is it normal for it to be like super swollen there's like a big long like starting from his shoulder all the way down to his elbow and it's red patchy and he's still running a slight fever and if you can please give me a call back. Just making sure if it's more more for if I should make him an appointment with his doctor. Thank you."
Patient had immunizations on 3/25 - was fed 30 minutes later, did well after 1 hour later patient seemed jittery to parents and patient would jerk with slightest touch.  Patient had temperature of 101 24 hours later.  Patient given Tylenol.  Treated in our office.  2 hours later 99.6.  Patient seen after nl exam on 3/26 except HR 160.
Information has been received from a physician concerning an adult female who was vaccinated with two doses of measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live as a child. Subsequently, during prenatal screening, the patient was found to have a negative rubella antibody titer. Unspecified medical attention was sought. No product quality complaint was involved. The reporter felt that the negative titer was another important medical event (OMIC). Additional information has been requested.
Warm sensation over entire body after shot given at approximately 1:50pm on 3/8/21. Followed by immediate strong tingling sensation on right leg as walking toward chair. Was monitored for 40 minutes without any other symptoms.  Kept trying to walk it off with no improvement.. Left site due to not having ?life threatening symptoms? Numbing leg felt for 15 hours. By the next day 3/9/21, 5:30am tingling and numbing felt still on right leg, PLUS left leg,  left arm, and both hands.  Went to ER of same location before 7am. Not seen until nearly 10am. Ruled out stroke or allergic reactions. Bloodwork and urinalysis came back normal. ER doctor said to go home and wait another 24 hours. Come back if symptoms progressed or trouble breathing. By 12am 3/10/21, tingling felt on left and right part of the chest and under tongue. Went to  different ER. Dr suggested to report it but that it could be attributed to nerve damage, not necessarily Moderna caused. And must seek neurologist to further analyze.
Left breast pain x 2 days, left axillary swelling/tenderness x 1 day, chest heaviness x 1 day
in July we got the Covid me and her and both of our shots are up to date and everything; in July we got the Covid me and her and both of our shots are up to date and everything; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP).  A patient (no qualifiers provided) received BNT162b2 (BNT162B2), on 03Jun2022 as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), on 10Nov2021 as dose 1, single (Batch/Lot number: unknown) and on 01Dec2021 as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset Jul2022, outcome "unknown" and all described as "in July we got the Covid me and her and both of our shots are up to date and everything". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (Jul2022) Positive, notes: in July we got the Covid.  Clinical course: Except in July reporter and grand child got the Covid, the reporter and grand child and both of their shots are up to date and everything, the reporter mean everything she wasn't even sick, and the reporter wasn't sick either, but suddenly both tested positive at home test and reporter's granddaughter had.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
PATIENT DESCRIBES SORENESS, PAIN, AND DECREASED RANGE OF MOTION IN THE LEFT ARM AS WELL AS SOME PAIN RUNNING INTO THE NECK REGION AS WELL
Information has been received from a physician and a practice manager referring to a patient of unknown age and gender. On 07-OCT-2014 the patient was vaccinated with an improperly stored dose of PNEUMOVAX 23 (strength: 0.5ml, lot # K004281, expire date 22-MAR-2015; dose and route unknown). The total cumulative excursion time was 1488 hours with the lowest recorded temperature of 20 Fahrenheit degree. The storage criteria and the type of excursion for this vaccine was refrigerator (R). No adverse effects were reported. This is one of several reports received from the same source. Additional information has been requested.
Patient was given the COVID-19 Moderna shot around 7:35pm. Few minutes later her husband alerted us that patient was vomiting. Patient wasn't sure but was thinking her throat might be tightening up, at which point I gave her 50mg of liquid oral Benadryl (7:40pm) just to see how patient will respond and EMT was alerted.  Patient said she was feeling better but few minutes later she said that she felt that her throat might be getting worse, at which point I gave her Epipen 0.3mg (7:45pm) just as EMT arrived. EMT automatically took over and few minutes later took the patient to the hospital.
little red mark in the injection side.; injection site redness; pain; touch; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE ERYTHEMA (little red mark in the injection side.), INJECTION SITE ERYTHEMA (injection site redness), PAIN (pain) and HYPERAESTHESIA (touch) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 036C21A and 008C21A) for COVID-19 vaccination.     Patient medical history was not provided by the reporter.    On 24-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 24-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE ERYTHEMA (little red mark in the injection side.). an unknown date, the patient experienced INJECTION SITE ERYTHEMA (injection site redness), PAIN (pain) and HYPERAESTHESIA (touch). At the time of the report, VACCINATION SITE ERYTHEMA (little red mark in the injection side.), INJECTION SITE ERYTHEMA (injection site redness), PAIN (pain) and HYPERAESTHESIA (touch) outcome was unknown.
Patient received COVID Pfizer vaccine on 2/22/21 and 3/16/21. Pt became COVID + on 4/19/21. Pt admitted in the hospital on 4/19/21
shoulder discomfort vaccination site, mild covid symptoms, fatigue, chills, lack of appetite, mild temp
much more tired than usual started 2 days after the vax, lasted about 10 days
Took a nap after the shot. When I woke up about an 1.5 later my right eye was blurred. I waited for a few hours to see if it would correct itself. I called the doctor after a few hours when my eye was the same.  I needed to know more, so I went to my own eye doctor and got an eye exam and she confirmed it changed.
Client received vaccine on 10/18/2021 at 4:50 pm adverse reaction begin same date (10/18/2021) at 5:20 pm. Reaction of hives on arms, swelling and bubble bump on right hand.  Right side of face, cheeks, and gums swollen.  Rash underarms, groin area, and abdomen began later that day.   Right side to left side of mouth swollen.  Rash was uncomfortable and had burning sensation.  Had slurred speech from swollen mouth.  Did not have any respiratory distress.  Contact PCP, made aware, was told to continue daily Zyrtec, then added Benadryl to help with swelling and rash reaction.
I developed significant hearing loss in my left ear. The only treatment I received was Prednisone for 3 weeks. They did a hearing test and I had and MRI after that, which was inconclusive. Now I have another test done for autoimmune disease but I have not received the results yet.
This is a spontaneous report from a contactable Physician, through a Pfizer Sales Representative. A female patient was administered with PREVNAR 13 single dose, unknown route on an unknown site at an unknown time for immunisation on an unknown date. Anatomical location of the administration of the vaccine was unknown. Relevant medical history was unknown. Relevant concomitant medications were unknown. Vaccines given on the same day were unknown. Vaccines taken within the last four weeks were unknown. On an unknown date while on PREVNAR 13 unknown dose unknown frequency on an unknown site at an unknown time the patient had localized swelling at the site of injection. It was unknown if the patient had any siblings. Relevant lab data was unknown. At the time of report it was unknown if the patient was taking PREVNAR 13. At the time of report the clinical outcome of the above mentioned event was unknown. Follow-up attempts completed. No further information expected.
was tested positive of Covid-19; was tested positive of Covid-19; This is a spontaneous report from a consumer (patient) via Pfizer sponsored program. A female patient of an unspecified age received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, lot number and expiration date were not reported) via an unspecified route of administration on 27Mar2021 as a single dose for covid-19 immunization. The patient medical history and concomitant medications were not reported. The patient received the 1st dose of vaccine on 27Mar2021, and she was tested positive for Covid-19 on an unspecified date. The patient was about to finish her quarantine on Saturday 17Apr2021. She is due to take her 2nd dose on 20Apr2021. she wanted to know if she can still get her 2nd shot. The outcome of the events was unknown.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
The patient reports itching that started the day after his vaccination. The patient still has itching as of January following immunization and was very uncomfortable while talking - rubbing his arms and legs.  He has been treated by multiple medications in an attempt to help with the itching. He has had famotidine, Benadryl, hydroxyzine, gabapentin, and multiple creams/lotions to help with the itching and pain.
pt states that her left arm is sore all the way to her shoulder.  Her left arm is also itchy, red, and swollen around the injection site which is warm to the touch.  Pt has not contacted PCP regarding these symptoms yet.
Pt had a grand mal seizure apparently unassociated with fever, 12 hours, post vax. She had no respiratory compromise and recovered well, but was seen in the ER.
WITHIN FEW MINUTES AFTER GIVING THE SHOTS, WHILE PATIENT JUST SAT DOWN ON THE CHAIR IN THE WAITING STARTED NOT FEELING GOOD. SHE COMPLAINED OF FEELING HOT,AND SHE FELT AS IF SHE WILL FAINT AND ALSO SHORTNESS OF BREATH. CHECKED HER OXYGEN MACHINE ,WHICH NOW SHOWING LOW BATTERY. CALLED 911. PATIENT WAS IN OBSERVANCE OF THE PHARMACIST WHILE ONE OF THE PHARMACY ASSOCIATE CALLED 911 AND FOLLOWED THE INSTRUCTIONS BY THEM. PATIENT STARTED FEELING BETTER IN ABOUT 5 TO 7 MINUTES BEFORE EVEN AMBULANCE ARRIVED.  EMT TOOK OVER. PATIENT STARTED FEELING MUCH BETTER AND WENT HOME WITH HER SON.
PHONE CALL FROM CLIENTS PHYSICIAN REPORTING A LOCAL REACTION OF SWELLING, REDNESS AND WARMTH IN THE RIGHT UPPER ARM.
None: No signs or symptoms noted or reported.  vaccine was left out overnight and a dose was given the next morning
fever; red face; chills; Pain in arm; headache; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (fever), ERYTHEMA (red face), CHILLS (chills), PAIN IN EXTREMITY (Pain in arm) and HEADACHE (headache) in a 40-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 07-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 07-Mar-2021, the patient experienced PYREXIA (fever), ERYTHEMA (red face), CHILLS (chills), PAIN IN EXTREMITY (Pain in arm) and HEADACHE (headache). The patient was treated with PARACETAMOL (TYLENOL) at a dose of 1 dosage form. At the time of the report, PYREXIA (fever), ERYTHEMA (red face), CHILLS (chills), PAIN IN EXTREMITY (Pain in arm) and HEADACHE (headache) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 07-Mar-2021, Body temperature: 102.4 (Inconclusive) 102.4.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication were provided.
Patient reported feeling dizziness approx. 10 mins after receiving the pfizer vaccine. Gave 8 oz. of orange juice and the patient reported feeling better after 5 mins. Monitored for 20 mins and no other symptoms were observed.
This is a spontaneous report from a Pfizer sponsored program received via a contactable consumer reporting for herself. A 76-year-old female patient received PREVNAR 13, via an unspecified route of administration, on 19Oct2016, at single dose, for immunisation. The patient's medical history and concomitant medications were not reported. The patient experienced pain in neck, headache, stiff neck and stiff glands all on 26Oct2016 with outcome of unknown.
10 days after vaccine administration, experienced fairly sudden onset of a sensation of burning, warmth, soreness and tenderness to touch on inner forearm of both arms, extending up to base of thumb. This initially lasted 5 hours and made it difficult to sleep, then went away and then came back about 12 hours later, lasting for 4 more hours, then resolved. Hasn?t reoccurred since that time. No inciting causes that I am aware of and nothing like this has ever happened to me before. Wondering if it could have been vaccine related.
This spontaneous case was initially received on 17-Nov-2015. The case report from a Health Professional and concerns a elderly female patient who was in her late sixties to early seventies. Weight: not provided, Height: not provided. For concomitant medication and therapy dates refer to the appropriate report sections. The patient received unspecified flu vaccine. PNEUMOVAX 23. On an unknown date, 6 days after starting treatment with unspecified flu vaccine and PNEUMOVAX vaccine, the patient experienced significant redness at the injection site, and significant swelling at the injection site. For relevant test results see appropriate report section.
Information has been received from a registered nurse referring to an unspecified number of patients of unknown ages and genders. The patients' medical histories, concurrent conditions and concomitant therapies were not reported. On unknown dates, the patients received an improperly stored dose of GARDASIL 9 (lot # M009378, expiration date 23-APR-2016; dose unknown) intramuscularly. No adverse effect was reported. The vaccines were stored under the temperature 1.9 Celsius degree for 6 minutes. There was no previous temperature excursion. A digital data logger was involved. This is one of several reports received rom the same reporter. Additional information has been requested.
My arm swell up to the elbow. Also, I could not move for a day and a half
No additional AE reported; a 15-month-old child received an adult dose of VAQTA; a 15-month-old child received an adult dose of VAQTA; This spontaneous report was received from a certified medical assistant and refers to a 15-month-old patient of unknown gender. The patient's medical history, concurrent conditions and concomitant medications were not provided.  On 26-FEB-2021, the patient was vaccinated with the first, 1 ml, adult dose of hepatitis a vaccine, inactivated (VAQTA) (lot # T014589, expiration date 25-OCT-2021; site and route of administration were not reported) for prophylaxis. No additional adverse events had been reported since dose was administered.